HCW Biologics Inc. (HCWB) quarterly income statement — complete revenue, gross profit & net income history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Sales/Revenue | 6.54M | 27.01K | 15.61K | 6.55K | 5.07K | 394.8K | 426.42K | 618.85K | 1.13M | 1.32M | 853.1K | 622.81K | 41.88K | 1.34M | 1.81M | 454K | 3.12M | 0 | 0 | 0 |
| Revenue Growth % | 129080.65% | -93.16% | -96.34% | -98.94% | -99.55% | -70.18% | -50.02% | -0.63% | 2590.14% | -1.31% | -52.84% | 37.18% | -98.66% | - | - | - | - | -100% | - | - |
| Cost of Goods Sold | 11.07K | 21.61K | 12.48K | 5.24K | 4.05K | 315.84K | 341.14K | 438.44K | 511.96K | 6.32M | 678.33K | 502.4K | 29.35K | 1.07M | 1.45M | 287.2K | 1.33M | 0 | 0 | 0 |
| COGS % of Revenue | 0.17% | 80% | 80% | 80% | 80% | 80% | 80% | 70.85% | 45.44% | 477.44% | 79.51% | 80.67% | 70.08% | 80% | 80% | 63.26% | 42.6% | - | - | - |
| Gross Profit | 6.53M | 5.4K | 3.12K | 1.31K | 1.01K | 78.96K | 85.28K | 180.41K | 614.75K | -5M | 174.78K | 120.41K | 12.53K | 268.3K | 361.81K | 166.8K | 1.79M | 0 | 0 | 0 |
| Gross Margin % | 99.83% | 20% | 20% | 20% | 20% | 20% | 20% | 29.15% | 54.56% | -377.44% | 20.49% | 19.33% | 29.92% | 20% | 20% | 36.74% | 57.4% | - | - | - |
| Gross Profit Growth % | 644710.46% | -93.16% | -96.34% | -99.27% | -99.84% | 101.58% | -51.2% | 49.84% | 4805.03% | -1962.57% | -51.69% | -27.81% | -99.3% | - | - | - | - | -100% | - | - |
| Operating Expenses | 3.29M | 2.95M | 3.28M | 3.47M | 1.97M | 3.24M | 3.78M | 15.32M | 8.11M | 5.77M | 5.25M | 4.63M | 5.37M | 5.94M | 4.38M | 3.68M | 3.67M | 3.11M | 4.09M | 2.75M |
| OpEx % of Revenue | 50.21% | 10932.28% | 21015.92% | 52906.67% | 38831.49% | 820.34% | 885.39% | 2474.97% | 719.65% | 435.86% | 615.71% | 743.56% | 12828.84% | 442.45% | 242.2% | 810.11% | 117.73% | - | - | - |
| Selling, General & Admin | 1.83M | 1.56M | 1.82M | 2.08M | 153.81K | 1.59M | 2.61M | 11.92M | 5.92M | 3.66M | 3.52M | 2.95M | 3.05M | 2.75M | 1.7M | 1.69M | 1.84M | 1.68M | 1.42M | 1.09M |
| SG&A % of Revenue | 28.02% | 5781.38% | 11643.26% | 31712.29% | 3036.68% | 402.05% | 613.13% | 1926.24% | 525.25% | 276.18% | 412.86% | 473.58% | 7277.6% | 205.11% | 94.01% | 372.48% | 59.18% | - | - | - |
| Research & Development | 1.26M | 1.33M | 1.4M | 1.23M | 1.48M | 1.05M | 1.19M | 2.03M | 2.12M | 2.14M | 1.67M | 1.62M | 2.26M | 2.93M | 2.65M | 1.97M | 1.79M | 1.48M | 2.69M | 1.67M |
| R&D % of Revenue | 19.23% | 4935.58% | 8998.12% | 18730.14% | 29194.69% | 265.86% | 278.34% | 327.89% | 188.45% | 161.36% | 195.46% | 259.58% | 5385.99% | 218.41% | 146.42% | 433.89% | 57.41% | - | - | - |
| Other Operating Expenses | 193.93K | 58.16K | 58.45K | 161.41K | 334.3K | 601.81K | -25.9K | 1000K | 67.08K | -22.2K | 63.08K | 64.8K | 69.21K | 253.97K | 31.94K | 16.94K | 35.6K | -55.4K | -19.2K | -14.62K |
| Operating Income | 3.24M | -2.95M | -3.28M | -3.46M | -1.97M | -3.16M | -3.69M | -15.14M | -7.49M | -10.77M | -5.08M | -4.51M | -5.36M | -5.67M | -4.02M | -3.51M | -1.88M | -3.11M | -4.09M | -2.75M |
| Operating Margin % | 49.45% | -10912.29% | -20995.92% | -52886.67% | -38811.49% | -800.34% | -865.39% | -2445.81% | -665.09% | -813.31% | -595.23% | -724.22% | -12798.92% | -422.45% | -222.2% | -773.37% | -60.33% | - | - | - |
| Operating Income Growth % | 264.6% | 6.72% | 11.21% | 77.11% | 73.77% | 70.66% | 27.33% | -235.57% | -39.79% | -90.01% | -26.33% | -28.47% | -185.01% | -82.08% | 1.77% | -27.63% | 44.88% | -251.01% | - | - |
| EBITDA | 3.38M | -2.79M | -3.1M | -3.17M | -1.55M | -2.48M | -3.56M | -15.01M | -7.25M | -10.57M | -4.8M | -4.23M | -5.06M | -5.41M | -3.86M | -3.36M | -1.74M | -3.02M | -3.97M | -2.59M |
| EBITDA Margin % | 51.62% | -10331.24% | -19881.58% | -48429.94% | -30538.84% | -627.46% | -835.27% | -2424.82% | -643.48% | -798.04% | -562.7% | -678.57% | -12085.39% | -402.98% | -213.12% | -740.42% | -55.75% | - | - | - |
| EBITDA Growth % | 318.37% | -12.64% | 12.89% | 78.86% | 78.67% | 76.55% | 25.8% | -255.07% | -43.24% | -95.45% | -24.51% | -25.72% | -191.23% | -79.19% | 2.84% | -29.99% | 46.58% | -235.6% | - | - |
| D&A (Non-Cash Add-back) | 142.05K | 156.94K | 173.91K | 291.92K | 419.01K | 682.51K | 128.45K | 129.93K | 243.5K | 202.11K | 277.45K | 284.33K | 298.85K | 261.16K | 164.33K | 149.58K | 142.78K | 95.58K | 124.12K | 165.09K |
| EBIT | 3.69M | 945.77K | -4.41M | -1.6M | -1.67M | -2.6M | -3.68M | -15.12M | -7.47M | -10.68M | -4.84M | -4.21M | -4.98M | -5.36M | -3.88M | -3.51M | -2.06M | -3.17M | -4.09M | -2.75M |
| Net Interest Income | 109.27K | -226.54K | -142.57K | -228.71K | -255.82K | -248.11K | -223.36K | -159.67K | 0 | 1.42K | -95.51K | -95.51K | -93.44K | -56.24K | -32.18K | 516 | -176.4K | -60.9K | -2.54K | 631 |
| Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.42K | 0 | 0 | 0 | 0 | 0 | 516 | 0 | 0 | 0 | 631 |
| Interest Expense | -109.27K | 226.54K | 142.57K | 228.71K | 255.82K | 248.11K | 223.36K | 159.67K | 0 | 0 | 95.51K | 95.51K | 93.44K | 0 | 32.18K | 0 | 176.4K | 60.9K | 2.54K | 0 |
| Other Income/Expense | 566.96K | 3.67M | -1.28M | 1.54M | -231.07K | -213.51K | -212.05K | -144.18K | 25.6K | 87.66K | 139.24K | 206.1K | 289.88K | 248.5K | 105.46K | 516 | -176.4K | -60.9K | -2.54K | 631 |
| Pretax Income | 3.8M | 719.23K | -4.55M | -1.93M | -2.2M | -3.37M | -3.9M | -15.28M | -7.47M | -10.68M | -4.94M | -4.3M | -5.07M | -5.42M | -3.91M | -3.51M | -2.06M | -3.17M | -4.09M | -2.75M |
| Pretax Margin % | 58.12% | 2662.84% | -29183.24% | -29430.99% | -43373.64% | -854.42% | -915.12% | -2469.11% | -662.82% | -806.69% | -578.9% | -691.13% | -12106.79% | -403.93% | -216.37% | -773.25% | -65.99% | - | - | - |
| Income Tax | -330.19K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | -8.68% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | 4.13M | 719.23K | -4.55M | -1.93M | -2.2M | -3.37M | -3.9M | -15.28M | -7.47M | -10.68M | -4.94M | -4.3M | -5.07M | -5.42M | -3.91M | -3.51M | -2.06M | -3.17M | -4.09M | -2.75M |
| Net Margin % | 63.16% | 2662.84% | -29183.24% | -29430.99% | -43373.64% | -854.42% | -915.12% | -2469.11% | -662.82% | -806.69% | -578.9% | -691.13% | -12106.79% | -403.93% | -216.37% | -773.14% | -65.99% | - | - | - |
| Net Income Growth % | 288.12% | 121.32% | -16.71% | 87.38% | 70.58% | 68.42% | 20.98% | -254.99% | -47.28% | -97.1% | -26.17% | -22.63% | -146.48% | -70.75% | 4.41% | -27.62% | 27.66% | -253.99% | - | - |
| Net Income (Continuing) | 4.13M | 719.23K | -4.55M | -1.93M | -2.2M | -3.37M | -3.9M | -15.28M | -7.47M | -10.68M | -4.94M | -4.3M | -5.07M | -5.42M | -3.91M | -3.51M | -2.06M | -3.17M | -4.09M | -2.75M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | 11.82 | -9.90 | -12.12 | -40.74 | -0.30 | -0.52 | -0.60 | -2.40 | -1.20 | -1.80 | -0.84 | -0.72 | -0.84 | -0.90 | -0.66 | -0.59 | -0.35 | -0.66 | -0.84 | -0.57 |
| EPS Growth % | 4104.06% | -1796.55% | -1920% | -1597.5% | 75.4% | 71% | 28.57% | -233.33% | -42.86% | -100% | -27.27% | -22.45% | -143.48% | -36.36% | 21.43% | -3.81% | 40.72% | -252.78% | - | - |
| EPS (Basic) | 11.82 | -9.90 | -12.12 | -40.74 | -0.30 | -0.52 | -0.60 | -2.40 | -1.20 | -1.80 | -0.84 | -0.72 | -0.84 | -0.90 | -0.66 | -0.59 | -0.35 | -0.66 | -0.84 | -0.57 |
| Diluted Shares Outstanding | 349.62K | 349.62K | 376.68K | 296.69K | 7.45M | 6.47M | 6.3M | 6.3M | 6.2M | 6M | 5.99M | 5.99M | 5.98M | 5.98M | 5.97M | 5.97M | 5.96M | 4.93M | 4.93M | 5.71M |
| Basic Shares Outstanding | 349.62K | 349.62K | 376.68K | 296.69K | 7.45M | 6.47M | 6.3M | 6.3M | 6.2M | 6M | 5.99M | 5.99M | 5.98M | 5.98M | 5.97M | 5.97M | 5.96M | 4.93M | 4.93M | 5.71M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |